181 related articles for article (PubMed ID: 37545293)
1. Exploration of mRNA nanoparticles based on DOTAP through optimization of the helper lipids.
Ma X; Wu F; Peng C; Chen H; Zhang D; Han T
Biotechnol J; 2023 Nov; 18(11):e2300123. PubMed ID: 37545293
[TBL] [Abstract][Full Text] [Related]
2. Optimization of Lipid Nanoformulations for Effective mRNA Delivery.
Chen H; Ren X; Xu S; Zhang D; Han T
Int J Nanomedicine; 2022; 17():2893-2905. PubMed ID: 35814615
[TBL] [Abstract][Full Text] [Related]
3. Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery.
Sun M; Dang UJ; Yuan Y; Psaras AM; Osipitan O; Brooks TA; Lu F; Di Pasqua AJ
AAPS PharmSciTech; 2022 May; 23(5):135. PubMed ID: 35534697
[TBL] [Abstract][Full Text] [Related]
4. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
[TBL] [Abstract][Full Text] [Related]
5. Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection.
Lou G; Anderluzzi G; Schmidt ST; Woods S; Gallorini S; Brazzoli M; Giusti F; Ferlenghi I; Johnson RN; Roberts CW; O'Hagan DT; Baudner BC; Perrie Y
J Control Release; 2020 Sep; 325():370-379. PubMed ID: 32619745
[TBL] [Abstract][Full Text] [Related]
6. Modulating Lipid Nanoparticles with Histidinamide-Conjugated Cholesterol for Improved Intracellular Delivery of mRNA.
Jung O; Jung HY; Thuy LT; Choi M; Kim S; Jeon HG; Yang J; Kim SM; Kim TD; Lee E; Kim Y; Choi JS
Adv Healthc Mater; 2024 Jun; 13(14):e2303857. PubMed ID: 38344923
[TBL] [Abstract][Full Text] [Related]
7. Effect of the combination of cationic lipid and phospholipid on gene-knockdown using siRNA lipoplexes in breast tumor cells and mouse lungs.
Hattori Y; Tang M; Aoki A; Ezaki M; Sakai H; Ozaki KI
Mol Med Rep; 2023 Oct; 28(4):. PubMed ID: 37594053
[TBL] [Abstract][Full Text] [Related]
8. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver.
Zhang R; El-Mayta R; Murdoch TJ; Warzecha CC; Billingsley MM; Shepherd SJ; Gong N; Wang L; Wilson JM; Lee D; Mitchell MJ
Biomater Sci; 2021 Feb; 9(4):1449-1463. PubMed ID: 33404020
[TBL] [Abstract][Full Text] [Related]
9. Multicomponent Lipid Nanoparticles for RNA Transfection.
Gretskaya N; Akimov M; Andreev D; Zalygin A; Belitskaya E; Zinchenko G; Fomina-Ageeva E; Mikhalyov I; Vodovozova E; Bezuglov V
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111773
[TBL] [Abstract][Full Text] [Related]
10. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
11. Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA).
Álvarez-Benedicto E; Farbiak L; Márquez Ramírez M; Wang X; Johnson LT; Mian O; Guerrero ED; Siegwart DJ
Biomater Sci; 2022 Jan; 10(2):549-559. PubMed ID: 34904974
[TBL] [Abstract][Full Text] [Related]
12. The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs.
LoPresti ST; Arral ML; Chaudhary N; Whitehead KA
J Control Release; 2022 May; 345():819-831. PubMed ID: 35346768
[TBL] [Abstract][Full Text] [Related]
13. Analytical Characterization of Heterogeneities in mRNA-Lipid Nanoparticles Using Sucrose Density Gradient Ultracentrifugation.
Vaidya A; Parande D; Khadse N; Vargas-Montoya N; Agarwal V; Ortiz C; Ellis G; Kaushal N; Sarode A; Karve S; DeRosa F
Anal Chem; 2024 Apr; 96(14):5570-5579. PubMed ID: 38529613
[TBL] [Abstract][Full Text] [Related]
14. Optimal combination of cationic lipid and phospholipid in cationic liposomes for gene knockdown in breast cancer cells and mouse lung using siRNA lipoplexes.
Hattori Y; Tang M; Torii S; Tomita K; Sagawa A; Inoue N; Yamagishi R; Ozaki KI
Mol Med Rep; 2022 Aug; 26(2):. PubMed ID: 35686555
[TBL] [Abstract][Full Text] [Related]
15. Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems.
Rezaee M; Oskuee RK; Nassirli H; Malaekeh-Nikouei B
J Control Release; 2016 Aug; 236():1-14. PubMed ID: 27317365
[TBL] [Abstract][Full Text] [Related]
16. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
[TBL] [Abstract][Full Text] [Related]
17. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of vein graft stenosis with a c-jun targeting DNAzyme in a cationic liposomal formulation containing 1,2-dioleoyl-3-trimethylammonium propane (DOTAP)/1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE).
Li Y; Bhindi R; Deng ZJ; Morton SW; Hammond PT; Khachigian LM
Int J Cardiol; 2013 Oct; 168(4):3659-64. PubMed ID: 23886527
[TBL] [Abstract][Full Text] [Related]
19. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA.
Ball RL; Hajj KA; Vizelman J; Bajaj P; Whitehead KA
Nano Lett; 2018 Jun; 18(6):3814-3822. PubMed ID: 29694050
[TBL] [Abstract][Full Text] [Related]
20. Lipoplexes formulation and optimisation: in vitro transfection studies reveal no correlation with in vivo vaccination studies.
McNeil SE; Vangala A; Bramwell VW; Hanson PJ; Perrie Y
Curr Drug Deliv; 2010 Apr; 7(2):175-87. PubMed ID: 20158478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]